- Home
- Publications
- Publication Search
- Publication Details
Title
A public-private partnership to unlock the untargeted kinome
Authors
Keywords
-
Journal
Nature Chemical Biology
Volume 9, Issue 1, Pages 3-6
Publisher
Springer Nature
Online
2012-12-14
DOI
10.1038/nchembio.1113
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Discovery of Potent and Selective Covalent Inhibitors of JNK
- (2012) Tinghu Zhang et al. CHEMISTRY & BIOLOGY
- Life Beyond Kinases: Structure-Based Discovery of Sorafenib as Nanomolar Antagonist of 5-HT Receptors
- (2012) Xingyu Lin et al. JOURNAL OF MEDICINAL CHEMISTRY
- Combinatorial drug therapy for cancer in the post-genomic era
- (2012) Bissan Al-Lazikani et al. NATURE BIOTECHNOLOGY
- A selective inhibitor reveals PI3Kγ dependence of TH17 cell differentiation
- (2012) Giovanna Bergamini et al. Nature Chemical Biology
- Potent and Selective Inhibitors of CK2 Kinase Identified through Structure-Guided Hybridization
- (2012) James E. Dowling et al. ACS Medicinal Chemistry Letters
- In Situ Kinase Profiling Reveals Functionally Relevant Properties of Native Kinases
- (2011) Matthew P. Patricelli et al. CHEMISTRY & BIOLOGY
- Specific CLK Inhibitors from a Novel Chemotype for Regulation of Alternative Splicing
- (2011) Oleg Fedorov et al. CHEMISTRY & BIOLOGY
- Structure-Based Design of Potent and Selective 3-Phosphoinositide-Dependent Kinase-1 (PDK1) Inhibitors
- (2011) Jesús R. Medina et al. JOURNAL OF MEDICINAL CHEMISTRY
- Too many roads not taken
- (2011) Aled M. Edwards et al. NATURE
- Comprehensive analysis of kinase inhibitor selectivity
- (2011) Mindy I Davis et al. NATURE BIOTECHNOLOGY
- Skepinone-L is a selective p38 mitogen-activated protein kinase inhibitor
- (2011) Solveigh C Koeberle et al. Nature Chemical Biology
- Characterization of a selective inhibitor of the Parkinson's disease kinase LRRK2
- (2011) Xianming Deng et al. Nature Chemical Biology
- Probing the Probes: Fitness Factors For Small Molecule Tools
- (2010) Paul Workman et al. CHEMISTRY & BIOLOGY
- MK-5108, a Highly Selective Aurora-A Kinase Inhibitor, Shows Antitumor Activity Alone and in Combination with Docetaxel
- (2010) T. Shimomura et al. MOLECULAR CANCER THERAPEUTICS
- Targeting Bcr–Abl by combining allosteric with ATP-binding-site inhibitors
- (2010) Jianming Zhang et al. NATURE
- Specific Btk inhibition suppresses B cell– and myeloid cell–mediated arthritis
- (2010) Julie A Di Paolo et al. Nature Chemical Biology
- The (un)targeted cancer kinome
- (2010) Oleg Fedorov et al. Nature Chemical Biology
- The art of the chemical probe
- (2010) Stephen V Frye Nature Chemical Biology
- Guidelines for the effective use of chemical inhibitors of protein function to understand their roles in cell regulation: Table 1
- (2009) Philip Cohen BIOCHEMICAL JOURNAL
- Evaluation of substituted 6-arylquinazolin-4-amines as potent and selective inhibitors of cdc2-like kinases (Clk)
- (2009) Bryan T. Mott et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- The case for open-access chemical biology
- (2009) Johan Weigelt EMBO REPORTS
- Improved ATM kinase inhibitor KU-60019 radiosensitizes glioma cells, compromises insulin, AKT and ERK prosurvival signaling, and inhibits migration and invasion
- (2009) S. E. Golding et al. MOLECULAR CANCER THERAPEUTICS
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started